Protective effect of isoflavone enriched soy β-conglycinin on osteoporosis in ovariectomized rats.

Abstract

Research shows that the consumption of soybean foods can reduce the incidence rate of bone fractures in women after menopause. The aim of this study was to investigate the effects of different complex of soy β-conglycinin (7S) and isoflavones (7S-ISO) on osteoporosis in ovariectomized rats. All treatments were administrated intragastrically to the groups every afternoon for 3 months. The treatments were administrated at 1mL·(100 g)-1 , the animals were given 50 mg·kg-1 ·d-1 ISO, and the concentration of protein was about 2wt. %. The bone mineral density (BMD) and the bone biomechanics results of left tibia' maximum load in the 7S-ISO group is significantly higher than in the ovariectomized group and the 7S group (p < .05). Otherwise, the serum tartrate-resistant acid phosphatase (s-TRACP), serum osteocalcin (s-BGP), and serum estradiol (s-E2 ) levels in 7S-ISO were all significantly different from the OVX, OVX + casein, and the OVX + 7S group (p < .05). The serum calcium (s-Ca) level was not significantly different among all the groups. 7S-ISO may exhibit moderate estrogenic activities and as compared to 7S and ISO in osteoporosis (OP) of ovariectomized rats. PRACTICAL APPLICATIONS: The effects of soy proteins on the health of females have always been a concern. It has been extensively reported soy 7S globulin (7S) as a type of trimer glycoprotein can depress blood fats. The aim of this study was to investigate the effects of different complex of soy β-conglycinin and isoflavones (ISO), the main storage proteins and polyphenols in soy, on osteoporosis in ovariectomized rats.